Zavegepant (Zavzpret) (Zavegepant) for Personal Injury
Drug Class: CGRP Receptor Antagonist (Gepant) — Intranasal Acute Treatment
Common Uses
- Acute treatment of migraine attacks with significant nausea
- Post-traumatic migraine when oral medications are difficult to take
- Acute migraine rescue with rapid nasal spray onset
- Migraine attacks where swallowing tablets is not practical
How It Helps in Personal Injury Cases
Zavegepant (Zavzpret) is the first and only intranasal CGRP antagonist for acute migraine. In personal injury cases, it is particularly appropriate for patients whose migraine attacks are accompanied by severe nausea that prevents them from swallowing tablets. The nasal spray route provides an alternative acute rescue option that is clinically distinct from oral gepants.
Zavegepant delivers CGRP receptor blockade via nasal spray, bypassing the gastrointestinal system. This route is clinically valuable for migraine patients with severe nausea — a common migraine symptom that can make oral medication unreliable. The nasal spray delivers the drug directly to the nasal mucosa for absorption, with onset of action within 15-30 minutes.
Zavegepant (Zavzpret) Nasal Spray for Acute Migraine After Injury
Zavegepant, sold as Zavzpret, is the first intranasal CGRP receptor antagonist — a nasal spray that treats acute migraine attacks without requiring the patient to swallow a tablet.
Why a Nasal Spray Matters
Migraine attacks are commonly accompanied by significant nausea and even vomiting. For patients whose nausea is severe, swallowing and retaining an oral tablet may be unreliable. Zavegepant delivers CGRP receptor blockade through the nasal mucosa — bypassing the GI tract entirely — ensuring effective drug absorption even during the worst attacks.
How It Works
Zavegepant blocks the CGRP receptor that drives migraine neuroinflammation and vasodilation. The nasal spray delivers 10mg of zavegepant in a single spray into one nostril at the onset of a migraine attack.
Clinical Evidence
Clinical trials demonstrated statistically significant pain freedom and freedom from the most bothersome symptom at 2 hours compared to placebo. Onset of action was observed within the first 15-30 minutes in responders.
Use in PI Cases
Zavegepant is prescribed when:
- Severe nausea makes oral medication impractical
- Rapid onset is clinically preferred over an oral option
- The patient's migraine presentation includes prominent nausea as a prescribing decision point
In personal injury documentation, the nasal spray prescription reflects a clinical determination that the patient's migraine involves significant nausea — adding a specific symptom dimension to the injury record.
Accessing Zavegepant Through LienScripts
Zavegepant is brand-name only with no generic alternative. LienScripts provides pharmacy lien coverage at $0 upfront cost for qualified personal injury patients.
Dosage Forms
- Nasal spray 10mg per actuation (one spray in one nostril)
Common Side Effects
- Nasal discomfort or altered taste after spraying
- Nausea (mild, less than with oral medications)
- Dizziness (uncommon)
- Nasal congestion
Frequently Asked Questions
Why would a doctor prescribe a nasal spray instead of a tablet for migraine?
Zavegepant nasal spray is prescribed when a patient experiences severe nausea during migraine attacks that makes swallowing tablets difficult or unreliable. The nasal route ensures drug delivery even when the patient cannot comfortably take oral medications.
How fast does zavegepant work?
Zavegepant provides relatively rapid onset, with meaningful pain relief observed within 15-30 minutes in clinical studies. This rapid onset is one of its advantages over oral medications, which require GI absorption.
Is zavegepant a preventive medication?
No. Zavegepant is an acute medication taken at the onset of a migraine attack. It does not prevent future attacks. Patients needing prevention also take a daily preventive like atogepant (Qulipta) or a monthly CGRP injection.
Is there a generic version of Zavzpret?
No. Zavegepant is available only as Zavzpret. There is no generic alternative.